Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Residency Update

30 Jan 2018 07:00

RNS Number : 2599D
Phoenix Group Holdings
30 January 2018
 

Phoenix Group Holdings

LEI: 21380031B1D56JRCE375

Notice to PGH shareholders and to holders of outstanding debt securities regarding change in the head office and tax residence of Phoenix Group Holdings ("PGH")

Further to the announcement dated 21 June 2017, notice is hereby given that with effect from 31 January 2018 the central management and control, and the head office, of PGH will move from Jersey to the United Kingdom, with the intention that PGH will be resident in the United Kingdom for tax purposes from such date.

With effect from 31 January 2018, the PRA will treat PGH, and not Phoenix Life Holdings Limited ("PLHL"), as the ultimate EEA insurance holding company of the Insurance Group.

Holders of the subordinated securities:

· £428,113,000 6.625 per cent. Guaranteed Subordinated Notes due 2025;

· £450,000,000 4.125 per cent. Tier 3 Notes due 2022 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme; and

· U.S.$500,000,000 5.375 per cent. Notes due 2027 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme,

each issued by PGH (together, the "Outstanding Subordinated Securities"), are hereby notified that as such, PGH will become the ultimate EEA insurance holding company and the Insurance Group Parent Entity and a member of the Insurance Group for the purposes of the terms and conditions of the Outstanding Subordinated Securities. This will result in the Outstanding Subordinated Securities (and not the relevant on-loan of the proceeds of the Outstanding Subordinated Securities) being the only relevant capital item for the purposes of the definition of "Capital Disqualification Event" under the Outstanding Subordinated Securities with effect from such date.

PLHL will no longer be required by the PRA to be taken into account for the purposes of the deferral of principal and interest on the Outstanding Subordinated Securities pursuant to the definitions of "Regulatory Deficiency Interest Deferral Event" and "Regulatory Deficiency Redemption Deferral Event".

Capitalised terms that are not defined in this announcement will have the meanings given to them in the terms and conditions of the Outstanding Subordinated Securities.

The change in tax residency is not expected to impact PGH shareholders, other than UK stamp duty reserve tax (currently levied at 0.5%) will be incurred on subsequent purchases of PGH depositary interests.

Any PGH shareholder who is uncertain of the implications of the change in PGH's tax residency on their investment is recommended to obtain professional advice.

The change in tax residency will not impact the terms and conditions of the £300,000,000 5.75 per cent. Bonds due 2021 (of which £121,610,000 remains outstanding).

For further information, please contact:

 

Debt investors:

Rashmin Shah, Group Treasurer, Phoenix Group

Telephone: +44 (0) 20 3735 0059

Email: rashmin.shah@thephoenixgroup.com

 

Equity investors/analysts:Sam Perowne, Head of Investor Relations, Phoenix GroupTelephone: +44 (0) 20 3735 0021

Email: Samuel.Perowne@thephoenixgroup.com

 

 

Website: www.thephoenixgroup.com

 

This notice does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEDFWUFASEDF
Date   Source Headline
3rd Jul 20233:30 pmRNSTotal Voting Rights
30th Jun 202311:30 amRNSPublication of a Prospectus
16th Jun 20233:01 pmRNSDirector Declaration
12th Jun 20231:30 pmRNSBlock Listing Return
7th Jun 20238:38 amRNSDirector/PDMR Shareholding
1st Jun 20231:24 pmRNSBlock Listing Application
1st Jun 20231:00 pmRNSTotal Voting Rights
16th May 202312:10 pmRNSDirector/PDMR Shareholding
11th May 20236:00 pmRNSDirectorate Change
10th May 20234:06 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSHolding(s) in Company
4th May 20232:19 pmRNSResult of AGM
2nd May 20233:00 pmRNSTotal Voting Rights
6th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSTotal Voting Rights
3rd Apr 20238:02 amRNSAcquisition
30th Mar 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20234:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:45 pmRNSNotice of AGM
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20235:00 pmRNSDirector/PDMR Shareholding
15th Mar 20235:30 pmRNSDirector/PDMR Shareholding
13th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNS2022 Annual Financial Report
10th Mar 20239:31 amRNSDirectorate Change - Replacement
10th Mar 20239:00 amRNSDirectorate Change
8th Mar 20234:00 pmRNSDirector/PDMR Shareholding
1st Mar 20232:00 pmRNSTotal Voting Rights
7th Feb 20233:45 pmRNSMiscellaneous - PGH/TCS Extension of Partnership
7th Feb 20232:30 pmRNSDirector/PDMR Shareholding
1st Feb 20232:00 pmRNSTotal Voting Rights
6th Jan 20234:30 pmRNSDirector/PDMR Shareholding
30th Dec 20221:00 pmRNSTotal Voting Rights
12th Dec 20224:30 pmRNSBlock listing Interim Review
7th Dec 20224:45 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSTrading Statement
30th Nov 20222:00 pmRNSTotal Voting Rights
8th Nov 20225:30 pmRNSDirector/PDMR Shareholding
31st Oct 20226:00 pmRNSTotal Voting Rights
12th Oct 20224:00 pmRNSDirectorate Change
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.